These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 5128490)

  • 21. [Fatal jaundice during treatment with rifampicin].
    Godeau P; Catz G; Cenac A; de Saint-Maur P; Radvanyi MF
    Ann Med Interne (Paris); 1972 Feb; 123(2):119-20. PubMed ID: 5055067
    [No Abstract]   [Full Text] [Related]  

  • 22. [Possibilities and prospects of intravascular irradiation of blood by helium-neon laser in patients with pulmonary tuberculosis].
    Eshankhanov ME; Khodzhaeva ME; Kozarez MI; Aliev ShT
    Probl Tuberk; 1993; (2):27-9. PubMed ID: 7984563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A hepatitis epidemic with 5 cases of fatal acute atrophy in patients under polychemiotherapy including rifampicin].
    Caroli J; Opolon P; Lechevallier R; Hadchouel P; Thomas M
    Rev Med Chir Mal Foie; 1971; 46(3):123-35. PubMed ID: 5110423
    [No Abstract]   [Full Text] [Related]  

  • 24. [Icterus caused by rifampicin and isoniazide].
    Haber I; Hubens H; Buyssens N
    Tijdschr Gastroenterol; 1974; 17(3):165-76. PubMed ID: 4454055
    [No Abstract]   [Full Text] [Related]  

  • 25. [Icterigenic hepatitis during the treatment with combined isoniazid and rifampicin. Clinical and experimental observations].
    Marche J; Hugues FC; Graisely B; Marche C
    Rev Tuberc Pneumol (Paris); 1971; 35(1):55-76. PubMed ID: 5559725
    [No Abstract]   [Full Text] [Related]  

  • 26. [Studies on short-course chemotherapy of tuberculosis. II. Liver function during 6-month chemotherapy of tuberculosis with hydrazide, rifampicin and pyrazinamide].
    Nikodemowicz E; Kamińska M; Caban M; Struzik T
    Pneumonol Pol; 1984 Oct; 52(10):503-12. PubMed ID: 6533580
    [No Abstract]   [Full Text] [Related]  

  • 27. [The effect of rifampicin and INH on the mouse liver].
    Kozma D; Tompa A; Schaff Z; Lapis K
    Prax Klin Pneumol; 1982 Oct; 36(10):429-33. PubMed ID: 7145819
    [No Abstract]   [Full Text] [Related]  

  • 28. [Side effects of rifampicin used intermittently in treatment of chronic pulmonary tuberculosis].
    Zierski M; Kucharska A; Wislawska-Orlowska B
    Gruzlica; 1973 Nov; 41(11):1139-45. PubMed ID: 4765794
    [No Abstract]   [Full Text] [Related]  

  • 29. [Histopathological and histochemical study of the liver during antituberculotic polychemotherapy in children ].
    Mihailovici MS
    Morphol Embryol (Bucur); 1987; 33(3):205-8. PubMed ID: 2958698
    [No Abstract]   [Full Text] [Related]  

  • 30. [Disturbance of liver function caused by postoperative administration of rifampicin and-or ethionamide from standpoint of surgical treatment for pulmonary tuberculosis (author's transl)].
    Kekkaku; 1974 Jul; 49(7):201-6. PubMed ID: 4431109
    [No Abstract]   [Full Text] [Related]  

  • 31. [Dynamics of various immunobiochemical and encephalographic indices during polychemotherapy of pulmonary tuberculosis patients].
    Sagalovich VIa; Medunitsyna ND; Andrzheiuk NI; Chelnokova NV; Sagalovich AV
    Probl Tuberk; 1982 Feb; (2):36-41. PubMed ID: 7063477
    [No Abstract]   [Full Text] [Related]  

  • 32. [Study of hepatic function in patients treated with rifampicin].
    Morère P; Bourreille J; Matray F; Stain JP; Métayer P
    Rev Tuberc Pneumol (Paris); 1970; 34(3):403-14. PubMed ID: 5510435
    [No Abstract]   [Full Text] [Related]  

  • 33. [The liver and rifampicin].
    Piéron R; Marien C; Jagueux M
    Cah Med; 1973 Jun; 14(6):447-51. PubMed ID: 4766668
    [No Abstract]   [Full Text] [Related]  

  • 34. [Fatal liver cell necrosis after short-term administration of isoniazid and rifampicin to a patient already under treatment with anti-epileptic agents].
    van der Grient AJ; Kelderman CS
    Ned Tijdschr Geneeskd; 1983 May; 127(21):931. PubMed ID: 6866145
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hepatotoxic action of rifampicin and isonicotinic acid hydrazide].
    Kozma D; Mihalik P; Schaff Z; Lapis K
    Probl Tuberk; 1982 Jul; (7):68-72. PubMed ID: 7134213
    [No Abstract]   [Full Text] [Related]  

  • 36. [Liver and kidney damage in rifampicin and ethambutol treatment].
    Kozma D; Mihalik P
    Z Erkr Atmungsorgane; 1984; 162(3):249-55. PubMed ID: 6485386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Jaundice associated with rifampicin.
    Hollins PJ; Simmons AV
    Tubercle; 1970 Sep; 51(3):328-32. PubMed ID: 5495656
    [No Abstract]   [Full Text] [Related]  

  • 38. [Study on the incidence of Australia antigen in a controlled experiment of treatment with rifampicin].
    Patricolo MR
    Arch Monaldi; 1974; 29(5-6):477-82. PubMed ID: 4467825
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experimental study of liver damage due to rifampicin and rifampicin-isoniazid combination].
    Rossolini A; Cellesi C; Debolini A
    Farmaco Prat; 1973 Jun; 28(6):345-55. PubMed ID: 4714054
    [No Abstract]   [Full Text] [Related]  

  • 40. Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.
    Engbaek HC; Heckscher T; Højgaard C; Larsen SO; Rasmussen KN; Vergmann B
    Eur J Respir Dis; 1982 Mar; 63(2):84-93. PubMed ID: 7040100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.